SEC Form 4 · accession 0001144204-17-032755
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Michael O'Brien
Officer — EVP of Finance
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2017 | S | 13,300 | $10.13 | D | 13,300 | D | |
| Common Stock | Jun 13, 2017 | S | 2,500 | $10.13 | D | 15,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock) | $2.75 | Jun 13, 2017 | M | 13,300 | D | Feb 2, 2017 | Feb 2, 2019 | Common Stock | 13,300 | 77,700 | D |
| Stock Option (to acquire common stock) | $3.40 | Jun 13, 2017 | M | 2,500 | D | Jan 22, 2016 | Jan 20, 2020 | Common Stock | 2,500 | 75,200 | D |